|
A HER-2/neu pulsed DC1 vaccine for patients with DCIS
|
5R01CA096997-06
|
$503,290
|
$25,165
|
CZERNIECKI, BRIAN
|
UNIVERSITY OF PENNSYLVANIA
|
|
A program of immune-based treatments for cancer
|
5K24CA093670-09
|
$183,021
|
$91,511
|
CARSON, WILLIAM
|
OHIO STATE UNIVERSITY
|
|
Activating robust immunity to tumor-associated antigens:mechanisms and biology
|
5R01CA138617-03
|
$301,913
|
$301,913
|
Janssen, Edith
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,586,956
|
$258,695
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA082103-13S1
|
$112,399
|
$2,248
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-13S2
|
$249,998
|
$5,000
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-13S3
|
$249,998
|
$5,000
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-13S4
|
$50,000
|
$1,000
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-13S5
|
$75,000
|
$1,500
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-13
|
$7,206,672
|
$144,133
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA091842-10S1
|
$49,953
|
$999
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-10S2
|
$75,000
|
$1,500
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA091842-10
|
$4,380,520
|
$87,610
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer immunotherapy with a live recombinant vaccine
|
5R01CA069632-13
|
$317,115
|
$79,279
|
PATERSON, YVONNE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Chile Gallbladder Cancer Study
|
ZIA CP010218-10540
|
$173,561
|
$69,424
|
Hsing, Ann
|
DCEG (NCI)
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-28
|
$450,001
|
$4,500
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
Control of Cytokine Gene Expression in Lymphoid/Myeloid Cells
|
ZIA BC 009283
|
$617,430
|
$617,429
|
Young, Howard
|
CCR (NCI)
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-25
|
$1,147,220
|
$11,472
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Developing new immunotherapies based of CD4+ T cells
|
ZIA BC 011037
|
$502,734
|
$50,273
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Differentiation of Granulocytes and Macrophages
|
5R37CA022556-33
|
$230,201
|
$230,201
|
METCALF, DONALD
|
WALTER AND ELIZA HALL INST MEDICAL RES
|
|
Eastern Cooperative Group Chair's Office
|
3U10CA086802-13S1
|
$2,561,235
|
$128,062
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Eastern Cooperative Group Chair's Office
|
5U10CA086802-13
|
$629,400
|
$31,470
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-17
|
$3,653,305
|
$365,331
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
HALT-C Study
|
ZIA CP005782-10070
|
$99,081
|
$4,954
|
O'Brien, Thomas
|
DCEG (NCI)
|
|
Illinois Oncology Research Association Community Clinical Oncology Program
|
5U10CA035113-28
|
$732,293
|
$14,646
|
Le-Lindqwister, Nguyet
|
ONCOLOGY-HEMATOLOGY ASSOC-CENTRAL ILL
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$550,354
|
$165,106
|
Hakim, Frances
|
CCR (NCI)
|
|
Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules
|
ZIA BC 011215
|
$245,980
|
$196,783
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
IMMUNOLOGIC CONTROL OF GAMMAHERPESVIRUS LATENCY
|
5R01CA096511-08
|
$270,317
|
$270,317
|
VIRGIN, HERBERT
|
WASHINGTON UNIVERSITY
|
|
Immunological Modulation of Ocular Tumor Metastases
|
5R01CA030276-30
|
$278,621
|
$55,724
|
NIEDERKORN, JERRY
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
Immunomodulation in melanoma therapy
|
5R01CA127565-04
|
$275,908
|
$137,954
|
CRAFT, NOAH
|
LA BIOMED RES INST/ HARBOR UCLA MED CTR
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-13S1
|
$108,772
|
$1,088
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-13S2
|
$49,994
|
$500
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-13
|
$1,145,097
|
$11,451
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
IP-10 Chemokine: Its Role in T Cell Recruitment and Disease
|
5R01CA069212-15
|
$383,924
|
$191,962
|
LUSTER, ANDREW
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Kalamazoo Community Clinical Oncology Program
|
5U10CA035184-27
|
$535,888
|
$10,718
|
LORD, RAYMOND
|
WEST MICHIGAN CANCER CENTER
|
|
Kansas City Clincal Oncology Program CCOP
|
2U10CA035176-27A1
|
$650,000
|
$6,500
|
GAUR, RAKESH
|
KANSAS CITY CLINICAL ONCOLOGY PROGRAM
|
|
Lymphoma Studies
|
ZIA SC 006741
|
$270,916
|
$5,418
|
Wilson, Wyndham
|
CCR (NCI)
|
|
Mechanism and Function of HECT E3s in Ubiquitin and ISG15 Conjugation
|
5R01CA072943-16
|
$262,363
|
$52,473
|
HUIBREGTSE, JON
|
UNIVERSITY OF TEXAS AUSTIN
|
|
Modulation of IFN action via novel regulatory factors
|
5R01CA078282-12
|
$319,724
|
$319,724
|
KALVAKOLANU, DHAN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Molecular Basis of Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis
|
5R01CA082057-13
|
$312,161
|
$312,161
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE
|
7R01CA097085-10
|
$355,772
|
$35,577
|
Chen, Lieping
|
YALE UNIVERSITY
|
|
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA045564-25
|
$572,575
|
$5,726
|
Schwartz, Michael
|
MOUNT SINAI MEDICAL CENTER (MIAMI BEACH)
|
|
North Shore CCOP
|
5U10CA035279-28
|
$599,459
|
$5,995
|
VINCIGUERRA, VINCENT
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Ochsner Community Clinical Oncology Program
|
2U10CA035272-27A1
|
$698,610
|
$13,972
|
FULORIA, JYOTSNA
|
OCHSNER CLINIC FOUNDATION
|
|
Oncolytic Virus Targets Brain Tumors
|
5R01CA124737-05
|
$305,017
|
$152,509
|
VAN DEN POL, ANTHONY
|
YALE UNIVERSITY
|
|
Ozark Health Ventures, LLC dba Cancer Research for the Ozarks
|
5U10CA045560-23
|
$589,085
|
$5,891
|
Carolla, Robert
|
OZARK HEALTH VENTURES, LLC
|
|
Pathogenesis of EBV Infection
|
5R01CA068051-16
|
$454,973
|
$22,749
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.
|
ZIA BC 010252
|
$948,048
|
$189,609
|
Ruscetti, Francis
|
CCR (NCI)
|
|
Phase I Trials of Anti-Cancer Agents
|
5U01CA076576-14
|
$739,271
|
$81,320
|
GREVER, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas
|
ZIA BC 010580
|
$46,106
|
$23,053
|
Warren, Katherine
|
CCR (NCI)
|
Total relevant funding to Interferon for this search: $7,337,825
|